144 related articles for article (PubMed ID: 20420577)
1. MDMA toxicity and pathological consequences: a review about experimental data and autopsy findings.
Turillazzi E; Riezzo I; Neri M; Bello S; Fineschi V
Curr Pharm Biotechnol; 2010 Aug; 11(5):500-9. PubMed ID: 20420577
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms underlying the hepatotoxic effects of ecstasy.
Carvalho M; Pontes H; Remião F; Bastos ML; Carvalho F
Curr Pharm Biotechnol; 2010 Aug; 11(5):476-95. PubMed ID: 20420570
[TBL] [Abstract][Full Text] [Related]
3. Causes and consequences of methamphetamine and MDMA toxicity.
Quinton MS; Yamamoto BK
AAPS J; 2006 May; 8(2):E337-47. PubMed ID: 16796384
[TBL] [Abstract][Full Text] [Related]
4. The cardiovascular and cardiac actions of ecstasy and its metabolites.
Shenouda SK; Carvalho F; Varner KJ
Curr Pharm Biotechnol; 2010 Aug; 11(5):470-5. PubMed ID: 20420571
[TBL] [Abstract][Full Text] [Related]
5. Causes and effects of cellular oxidative stress as a result of MDMA abuse.
Fiaschi AI; Cerretani D
Curr Pharm Biotechnol; 2010 Aug; 11(5):444-52. PubMed ID: 20420574
[TBL] [Abstract][Full Text] [Related]
6. Acute administration of 3,4-methylenedioxymethamphetamine (MDMA) induces oxidative stress, lipoperoxidation and TNFα-mediated apoptosis in rat liver.
Cerretani D; Bello S; Cantatore S; Fiaschi AI; Montefrancesco G; Neri M; Pomara C; Riezzo I; Fiore C; Bonsignore A; Turillazzi E; Fineschi V
Pharmacol Res; 2011 Nov; 64(5):517-27. PubMed ID: 21864684
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of MDMA (ecstasy)-induced oxidative stress, mitochondrial dysfunction, and organ damage.
Song BJ; Moon KH; Upreti VV; Eddington ND; Lee IJ
Curr Pharm Biotechnol; 2010 Aug; 11(5):434-43. PubMed ID: 20420575
[TBL] [Abstract][Full Text] [Related]
8. Post-mortem (re)distribution of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"): human and animal data.
De Letter EA; Stove CP; Lambert WE; Piette MH
Curr Pharm Biotechnol; 2010 Aug; 11(5):453-9. PubMed ID: 20420573
[TBL] [Abstract][Full Text] [Related]
9. Comparative effects of 3,4-methylenedioxymethamphetamine and 4-methylthioamphetamine on rat liver mitochondrial function.
Custódio JB; Santos MS; Gonçalves DI; Moreno AJ; Fernandes E; Bastos ML; Carvalho F; Vicente JA; Fernandes MA
Toxicology; 2010 Apr; 270(2-3):99-105. PubMed ID: 20138954
[TBL] [Abstract][Full Text] [Related]
10. Neurotoxicity of ecstasy (MDMA): an overview.
Sarkar S; Schmued L
Curr Pharm Biotechnol; 2010 Aug; 11(5):460-9. PubMed ID: 20420572
[TBL] [Abstract][Full Text] [Related]
11. The mixture of "ecstasy" and its metabolites is toxic to human SH-SY5Y differentiated cells at in vivo relevant concentrations.
Barbosa DJ; Capela JP; Silva R; Vilas-Boas V; Ferreira LM; Branco PS; Fernandes E; Bastos Mde L; Carvalho F
Arch Toxicol; 2014 Feb; 88(2):455-73. PubMed ID: 24101030
[TBL] [Abstract][Full Text] [Related]
12. "Ecstasy"-induced toxicity in SH-SY5Y differentiated cells: role of hyperthermia and metabolites.
Barbosa DJ; Capela JP; Silva R; Ferreira LM; Branco PS; Fernandes E; Bastos ML; Carvalho F
Arch Toxicol; 2014 Feb; 88(2):515-31. PubMed ID: 24177245
[TBL] [Abstract][Full Text] [Related]
13. Human pharmacology of MDMA: pharmacokinetics, metabolism, and disposition.
de la Torre R; Farré M; Roset PN; Pizarro N; Abanades S; Segura M; Segura J; Camí J
Ther Drug Monit; 2004 Apr; 26(2):137-44. PubMed ID: 15228154
[TBL] [Abstract][Full Text] [Related]
14. On the mechanisms underlying 3,4-methylenedioxymethamphetamine toxicity: the dilemma of the chicken and the egg.
Puerta E; Hervias I; Aguirre N
Neuropsychobiology; 2009; 60(3-4):119-29. PubMed ID: 19893329
[TBL] [Abstract][Full Text] [Related]
15. Involvement of mitochondrial/lysosomal toxic cross-talk in ecstasy induced liver toxicity under hyperthermic condition.
Pourahmad J; Eskandari MR; Nosrati M; Kobarfard F; Khajeamiri AR
Eur J Pharmacol; 2010 Sep; 643(2-3):162-9. PubMed ID: 20599925
[TBL] [Abstract][Full Text] [Related]
16. Elucidating the neurotoxic effects of MDMA and its analogs.
Karuppagounder SS; Bhattacharya D; Ahuja M; Suppiramaniam V; Deruiter J; Clark R; Dhanasekaran M
Life Sci; 2014 Apr; 101(1-2):37-42. PubMed ID: 24560859
[TBL] [Abstract][Full Text] [Related]
17. Memantine prevents MDMA-induced neurotoxicity.
Chipana C; Camarasa J; Pubill D; Escubedo E
Neurotoxicology; 2008 Jan; 29(1):179-83. PubMed ID: 17980434
[TBL] [Abstract][Full Text] [Related]
18. The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").
Green AR; Mechan AO; Elliott JM; O'Shea E; Colado MI
Pharmacol Rev; 2003 Sep; 55(3):463-508. PubMed ID: 12869661
[TBL] [Abstract][Full Text] [Related]
19. Interpretation of a 3,4-methylenedioxymethamphetamine (MDMA) blood level: discussion by means of a distribution study in two fatalities.
De Letter EA; Bouche MP; Van Bocxlaer JF; Lambert WE; Piette MH
Forensic Sci Int; 2004 May; 141(2-3):85-90. PubMed ID: 15062945
[TBL] [Abstract][Full Text] [Related]
20. Effect of 3,4-methylenedioxymethamphetamine ("ecstasy") on body temperature and liver antioxidant status in mice: influence of ambient temperature.
Carvalho M; Carvalho F; Remião F; de Lourdes Pereira M; Pires-das-Neves R; de Lourdes Bastos M
Arch Toxicol; 2002 Apr; 76(3):166-72. PubMed ID: 11967622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
